What happened

President Donald Trump Monday signed an executive order aimed at persuading pharmaceutical companies to lower the prices of U.S. prescription drugs. Trump's order gives companies a 30-day deadline to start voluntarily lowering prices or face potential consequences.

Who said what

The White House "teased the announcement as seismic," but Trump's order lacks "teeth" and "cites no obvious legal authority to mandate lower prices," The New York Times said. It was "something of a win" for drugmakers, which had been "bracing" for a "much more damaging" policy. "Far from demonizing pharmaceutical companies for high prices," The Washington Post said, Trump "focused his fire" on European countries "for negotiating drug prices so low" the U.S. picks up the "costs of innovation."

See Full Page